Nurse And Patient

EnClear Therapies

Device Based Therapeutic Solutions | Targeting Neurodegenerative Disease

At Enclear Therapies, our mission is to improve and extend the lives of genetically defined populations of patients suffering from neurodegenerative disease through the advancement of biomedical science and engineering to develop controlled access, delivery, and modification of cerebrospinal fluid.


Targeting toxic proteins in CSF

Enclear Therapies is developing device-based systems to halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The system 1. continuously recirculates cerebrospinal fluids (CSF) and 2. targets and removes toxic proteins from CSF.

Pipetting Samples

The EnClear Therapies Team

President & CEO, Co-Founder

Anthony R. DePasqua

  • 20yrs Med Tech Experience

  • Business & Product Dev, Marketing & Sales, Portfolio Strategy

  • Developed & Launched Platform Tech, Disposables & Services

  • Neuro, Ortho & Oncology


EnClear Therapies, Inc.
65 Parker Street #3A. Newburyport, MA 01950

EnClear Therapies, Inc.
65 Parker Street #3A. Newburyport, MA 01950

Phone: 978-358-1557

©2018 by EnClear Therapies. Proudly created with